XBI is trading at $153.75, down 3.67%, alongside declines across the broader market.

  • The S&P 500 is down 1.49%, while the Nasdaq is down 2.94%.
  • No clear XBI-specific catalyst surfaced in the available search, and Nasdaq’s XBI news page showed no updates.
  • The previous session’s biotech rally followed reduced regulatory concerns after the election, but that earlier optimism does not explain today’s decline. No trading-volume figure is available in the provided price context.